Teva sued over weight-loss generic

08-03-2017

Teva sued over weight-loss generic

Photo: Courtesy of Teva

US-based biopharmaceutical company Arena Pharmaceuticals and Eisai, a drugs company based in Japan, have filed a complaint against Teva for patent infringement over a weight-loss generic drug.  


Teva, ANDA, patent, FDA, Arena, Eisai, weight management, generic, patent infringement,

LSIPR